Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Adoption Of E-Health Records Gets Stimulus Of Medicare Rewards, Penalties

Executive Summary

A program to bring about wider adoption of health information technology in physicians' offices is mirroring the conceptual framework of rewarding and penalizing physicians through Medicare payments that was used to promote adoption of electronic prescribing

You may also be interested in...

Cancer Research Group Calls For EHR Link To Clinical Trial Databases

The American Association for Cancer Research recommends that meaningful use criteria include a requirement that electronic health records connect to clinical trial databases to encourage greater participation.

Drug Substitution Language In E-Health Record Regs Concerns PhRMA

The Pharmaceutical Research and Manufacturers of America and drug manufacturers offer comments on HHS’ proposed next-stage requirements for electronic health records, which physicians and hospitals will have to meet in order to qualify for incentive payments for the meaningful use of EHRs.

Drug Communication Via EHRs Will Improve Rx Adherence, Despite Lack Of HHS Standard, Official Says

Although a specific criterion directly measuring medication adherence is not part of the meaningful use standard for electronic health records, they offer tools to help ensure patients take their medications.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts